Carregant...
How Comparative Effectiveness Research Can Help To Advance ‘Personalized Medicine’ In Cancer Treatment
The use of biomarkers to “personalize” cancer treatment —identifying discrete genes, proteins, or other indicators that can differentiate one type of cancer from another and enable the use of highly tailored therapies -- offers tremendous potential for improved outcomes and lower treatment costs. Ho...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477796/ https://ncbi.nlm.nih.gov/pubmed/22147853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2010.0637 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|